Status:
COMPLETED
A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18+ years
Brief Summary
This study is being conducted as a regulatory requirement post initial marketing authorization. This is primarily a safety study. This was an open label study and patients were enrolled once the decis...
Eligibility Criteria
Inclusion
- Male or female, 18 years old and above diagnosed with neuropathic pain.
Exclusion
- Patients that are pregnant and lactating; and patients with known hypersensitivity to pregabalin or its related components.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
2278 Patients enrolled
Trial Details
Trial ID
NCT00892008
Start Date
September 1 2006
End Date
August 1 2008
Last Update
January 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.